BlackRock’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
4,040,236
+174,340
+5% +$627K ﹤0.01% 3285
2025
Q4
$13.2M Buy
3,865,896
+224,117
+6% +$1M ﹤0.01% 3325
2025
Q3
$18.3M Sell
3,641,779
-39,015
-1% -$172K ﹤0.01% 3139
2025
Q2
$12.6M Buy
3,680,794
+104,586
+3% +$260K ﹤0.01% 3287
2025
Q1
$7.97M Sell
3,576,208
-520,435
-13% -$1.49M ﹤0.01% 3431
2024
Q4
$12M Buy
4,096,643
+107,951
+3% +$301K ﹤0.01% 3332
2024
Q3
$10.4M Buy
3,988,692
+185,215
+5% +$513K ﹤0.01% 3389
2024
Q2
$11.3M Sell
3,803,477
-97,087
-2% -$367K ﹤0.01% 3323
2024
Q1
$17.7M Sell
3,900,564
-5,149
-0.1% -$26.3K ﹤0.01% 3060
2023
Q4
$22.3M Buy
3,905,713
+496,267
+15% +$2.3M ﹤0.01% 2953
2023
Q3
$15.7M Sell
3,409,446
-41,952
-1% -$255K ﹤0.01% 3078
2023
Q2
$22.3M Sell
3,451,398
-10,242,897
-75% -$69.9M ﹤0.01% 2976
2023
Q1
$103M Sell
13,694,295
-157,707
-1% -$1.43M ﹤0.01% 1996
2022
Q4
$140M Buy
13,852,002
+1,282,862
+10% +$14.8M ﹤0.01% 1776
2022
Q3
$124M Buy
12,569,140
+743,808
+6% +$8.16M ﹤0.01% 1819
2022
Q2
$126M Buy
11,825,332
+9,378,033
+383% +$79.4M ﹤0.01% 1875
2022
Q1
$23.9M Buy
2,447,299
+80,057
+3% +$758K ﹤0.01% 3061
2021
Q4
$33.9M Buy
2,367,242
+1,390,655
+142% +$21.1M ﹤0.01% 2939
2021
Q3
$19.6M Buy
976,587
+79,400
+9% +$1.4M ﹤0.01% 3291
2021
Q2
$19.7M Buy
897,187
+41,714
+5% +$1.15M ﹤0.01% 3316
2021
Q1
$29.1M Buy
855,473
+505,056
+144% +$20.1M ﹤0.01% 2970
2020
Q4
$14.1M Buy
+350,417
New +$16M ﹤0.01% 3192

Other funds holding ABCL